Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
暂无分享,去创建一个
J. Dipersio | M. Arcasoy | H. Kantarjian | S. Verstovsek | M. Deininger | R. Paquette | R. Mesa | M. Talpaz | R. Silver | A. Raza | Carole B. Miller | J. Gotlib | Vikas Gupta | E. Hexner | Mark M. Jones | J. Catalano | R. Lyons | E. Winton | K. Sun | J. Harvey | Deanna Kornacki | D. Kornacki